Selective antagonism of prostaglandin (PG) E1, PGD2 and prostacyclin (PGI2) on human and rabbit platelets by DI-4-phloretin phosphate (DPP)
- 1 June 1978
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 12 (6) , 973-978
- https://doi.org/10.1016/0049-3848(78)90053-1
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Discrimination between platelet prostaglandin receptors with a specific antagonist of bisenoic prostaglandinsThrombosis Research, 1977
- Effects of prostacyclin (PGX) on cyclic AMP concentrations in human plateletsProstaglandins, 1977
- Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac arteries and inhibits platelet aggregationProstaglandins, 1976
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976
- Patterns of fatty acid release from endogenous substrates by human platelet homogenates and membranes.Journal of Biological Chemistry, 1975
- Stimulation of human platelet adenylate cyclase by prostaglandin D2Thrombosis Research, 1974
- Prostaglandin D2 inhibits the aggregation of human plateletsThrombosis Research, 1974
- Relationship between chemical structure and plateletaggregation activity of prostaglandinsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1969
- Divergent effects of epinephrine and prostaglandin E1 on the level of cyclic AMP in human blood plateletsPharmacological Research Communications, 1969